Price-to-earnings: BT vs RX

The average P/E for profitable biotech was 14.5 at year end, down 13% from 16.8 at the end of 2008 and off 33% from 21.8 at the end of 2007. For big pharma, the average P/E rose 2% to 10.4 over the la...